SCHERING CORPORATION, Plaintiff,
v.
GENEVA PHARMACEUTICALS, INC. and Novartis Corporation,
Teva Pharmaceuticals, USA, Inc.,
Zenith Goldline Pharmaceuticals, Inc.,
Andrx Corporation, et al.,
Mylan Pharmaceuticals, Inc.,
American Home Products, et al., and
Impax Laboratories, Inc., Defendants.
United States District Court, D. New Jersey.https://leagle.com/images/logo.png
August 8, 2002.
August 8, 2002.
Attorney(s) appearing for the Case
Graham, Curtin & Sheridan, By: Thomas R. Curtin, George C. Jones, Janyce M. Wilson, Morristown, New Jersey, Kirkland & Ellis, By: Robert G. Krupka, Los Angeles, California, and Kirkland & Ellis, By: John M. Desmarais, Sandra A. Bresnick, Peter J. Armenio, Maxine Y. Graham, Monica V. Bhattacharyya, Young J. Park, New York, New York, for Plaintiff Schering Corporation.
Schiff Hardin & Waite, By: Douglass C. Hochstetler, Chicago, Illinois, Marshall, Gerstein & Borun, By: Kevin M. Flowers, Ph.D., Chicago, Illinois, and Sterns & Weinroth, By: Karen A. Confoy, Trenton, New Jersey, for Defendants Geneva Pharmaceuticals, Inc. and Novartis Corp.
Finnegan, Henderson, Farabow, Garrett & Dunner, By: Robert D. Bajefsky, David A. Manspeizer, Barbara R. Rudolph, William Z. Nakhleh, Washington, D.C., and Robinson & Livelli, By: Donald A. Robinson, Newark, New Jersey, for Defendants American home Products Corp., Wyeth-Ayerst Laboratories and ESI-Lederle.
Lite DePalma Greenberg & Rivas, By: Allyn Z. Lite, Joseph J. DePalma, Stephanie M. Kay, Newark, New Jersey, and Goodwin Proctor, By: Thomas L. Creel, Frederick H. Rein, Keith A. Zullow, New York, New York, for Defendant TEVA Pharmaceuticals USA, Inc.
Harwood Lloyd, By: Frank Holahan, Hackensack, New Jersey, and Rothwell, Figg, Ernst & Manbeck, By: E. Anthony Figg, Joseph A. Hynds, Washington, D.C., for Defendant Mylan Pharmaceuticals Inc.
Carella, Byrne, Bain, Gilfillan, Cecchi, Stewart & Olstein, By: James E. Cecchi, Roseland, New Jersey, and Wiley Rein & Fielding, By: James H. Wallace, Jr., Gregory R. Lyons, Mark A. Pacella, Washington, D.C., for Defendant Zenith Goldline Pharmaceuticals, Inc.
Solomon, Zauderer, Ellenhorn, Frischer & Sharp, By: Colin A. Underwood, Jonathan Lupkin, New York, New York, Hedman & Costigan, By: James V. Costigan, Martin P. Endres, New York, New York, and Greenbaum, Rowe, Smith, Ravin, Davis & Himmel, By: Michael B. Himmel, Woodbridge, New Jersey, for Defendants Andrx Corporation, Andrx Pharmaceuticals, Inc. and Andrx Pharmaceuticals, LLC.
Saiber, Schlesinger, Satz & Goldstein, By: Arnold B. Calmann, Newark, New Jersey, Venable, and Baetjer, Howard & Civiletti, By: Julie A. Petruzzelli, Peter J. Curtin, Washington, D.C., for Defendant Impax Laboratories, Inc.
United States District Court, D. New Jersey.
OPINION
BISSELL, Chief Judge.
This matter comes before the Court on Plaintiff's and Defendants' motions for summary judgment on Defendants' inherent anticipation defenses with regard to Claims 1 and 3 of Schering's '716 patent. This Court has jurisdiction over the matter pursuant to 28 U.S.C. § 1331.
PROCEDURAL BACKGROUND
Plaintiff Schering Corporation is a pharmaceutical company whose several patents are at stake in...
Let's get started
Welcome to the leading source of independent legal reporting Sign on now to see your case. Or view more than 10 million decisions and orders.
Updated daily.
Uncompromising quality.
Complete, Accurate, Current.
Listed below are the cases that are cited in this Featured Case. Click the citation to see the full
text of the cited case. Citations are also linked in the body of the Featured Case.
Cited Cases
No Cases Found
Listed below are those cases in which this Featured Case is cited. Click on the case name to see the
full text of the citing case.
